Ann C. Hewkin

1.6k total citations · 1 hit paper
16 papers, 1.1k citations indexed

About

Ann C. Hewkin is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, Ann C. Hewkin has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Pharmacology. Recurrent topics in Ann C. Hewkin's work include Blood Pressure and Hypertension Studies (10 papers), Pharmacology and Obesity Treatment (5 papers) and Hormonal Regulation and Hypertension (4 papers). Ann C. Hewkin is often cited by papers focused on Blood Pressure and Hypertension Studies (10 papers), Pharmacology and Obesity Treatment (5 papers) and Hormonal Regulation and Hypertension (4 papers). Ann C. Hewkin collaborates with scholars based in United States, United Kingdom and Italy. Ann C. Hewkin's co-authors include Carl J. Pepine, Stuart Kupfer, Franz H. Messerli, C Conti, Athanase Bénétos, R. Kolloch, Giuseppe Mancia, Annette Champion, Cheryl Renz and George L. Bakris and has published in prestigious journals such as Annals of Internal Medicine, Journal of the American College of Cardiology and Diabetes Care.

In The Last Decade

Ann C. Hewkin

15 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous?

2006 507 citations Franz H. Messerli, Giuseppe Mancia et al. Annals of Internal Medicine profile →

Peers

Countries citing papers authored by Ann C. Hewkin

Since Specialization

Citations

This map shows the geographic impact of Ann C. Hewkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann C. Hewkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann C. Hewkin more than expected).

Fields of papers citing papers by Ann C. Hewkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann C. Hewkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann C. Hewkin. The network helps show where Ann C. Hewkin may publish in the future.

Co-authorship network of co-authors of Ann C. Hewkin

This figure shows the co-authorship network connecting the top 25 collaborators of Ann C. Hewkin. A scholar is included among the top collaborators of Ann C. Hewkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann C. Hewkin. Ann C. Hewkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Sibutramine Plus Meal Replacement Therapy for Body Weight Loss and Maintenance in Obese Patients 2007 ·Obesity ·(unknown), Caroline M. Apovian, Louis J. Aronne, Madelyn H. Fernstrom, Arthur L. Frank, Frank L. Greenway, David Heber, Robert F. Kushner, (unknown), (unknown), Ann C. Hewkin, Vicky A. Blakesley	21
2	Cardiovascular Effects of Sibutramine in the Treatment of Obese Adolescents: Results of a Randomized, Double-Blind, Placebo-Controlled Study 2007 ·PEDIATRICS ·Stephen R. Daniels, Barbara Long, Scott J. Crow, Dennis M. Styne, Melinda Sothern, (unknown), (unknown), (unknown), (unknown), (unknown), Ann C. Hewkin, Vicky A. Blakesley, (unknown)	35
3	Predictors of Adverse Outcome Among Patients With Hypertension and Coronary Artery Disease 2006 ·Journal of the American College of Cardiology ·Carl J. Pepine, Peter R. Kowey, Stuart Kupfer, R. Kolloch, Athanase Bénétos, Giuseppe Mancia, António Coca, Rhonda M. Cooper‐DeHoff, Eileen Handberg, Efraín Gaxiola, Peter Sleight, C. Richard Conti, Ann C. Hewkin, Luigi Tavazzi	39
4	Lowering of Blood Pressure—The Lower, the Better? 2006 ·Journal of the American Society of Nephrology ·Franz H. Messerli, G. Mancia, C Conti, Ann C. Hewkin, Stuart Kupfer, Annette Champion, R. Kolloch, Athanase Bénétos, Carl J. Pepine	6
5	Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients—Findings From the International Verapamil SR/Trandolapril Study (INVEST) 2006 ·American Heart Journal ·Rhonda M. Cooper‐DeHoff, Juan M. Aranda, Efraín Gaxiola, José L. Cangiano, D García-Barreto, C Conti, Ann C. Hewkin, Carl J. Pepine	53
6	Predictors of Development of Diabetes Mellitus in Patients With Coronary Artery Disease Taking Antihypertensive Medications (Findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]) 2006 ·The American Journal of Cardiology ·Rhonda M. Cooper‐DeHoff, Jerome D. Cohen, George L. Bakris, Franz H. Messerli, Serap Erdine, Ann C. Hewkin, Stuart Kupfer, Carl J. Pepine	59
7	Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous? breakdown → 2006 ·Annals of Internal Medicine ·Franz H. Messerli, Giuseppe Mancia, C Conti, Ann C. Hewkin, Stuart Kupfer, Annette Champion, R. Kolloch, Athanase Bénétos, Carl J. Pepine	507
8	Effects of Sibutramine Treatment in Obese Adolescents 2006 ·Annals of Internal Medicine ·Robert I. Berkowitz, Ken Fujioka, Stephen R. Daniels, Alison G. Hoppin, (unknown), Arlette Perry, Melinda Sothern, Cheryl Renz, (unknown), (unknown), (unknown), Ann C. Hewkin, Vicky A. Blakesley, (unknown)	155
9	Differences in Glucose Tolerance Between Fixed-Dose Antihypertensive Drug Combinations in People With Metabolic Syndrome 2006 ·Diabetes Care ·George L. Bakris, Mark E. Molitch, Ann C. Hewkin, Mark Kipnes, Pantelis Sarafidis, Kaffa Fakouhi, Peter Bacher, James R. Sowers, (unknown)	122
10	Prediction of response to sibutramine therapy in obese non‐diabetic and diabetic patients 2005 ·Diabetes Obesity and Metabolism ·Nick Finer, Donna H. Ryan, Cheryl Renz, Ann C. Hewkin	51
11	A Drug Dose Model for Predicting Clinical Outcomes in Hypertensive Coronary Disease Patients 2005 ·Journal of Clinical Hypertension ·W.J. Elliott, Ann C. Hewkin, Stuart Kupfer, Rhonda M. Cooper‐DeHoff, Carl J. Pepine	8
12	Risk of adverse cardiovascular outcomes and new diabetes with combination therapy in hypertensive patients with coronary artery disease: the INternational VErapamil SR-Trandolapril STudy (INVEST) 2004 ·European Heart Journal ·Giuseppe Mancia, Mátyás Keltai, Serap Erdine, Ann C. Hewkin, Stuart Kupfer, Carl J. Pepine	0
13	Characteristics of contemporary patients with hypertension and coronary artery disease 2004 ·Clinical Cardiology ·Rhonda M. Cooper‐DeHoff, Eileen Handberg, Jerome D. Cohen, Peter R. Kowey, Franz H. Messerli, Giuseppe Mancia, José L. Cangiano, Efraín Gaxiola, D García-Barreto, Ann C. Hewkin, Carl J. Pepine	15
14	TRANDOLAPRIL IMPROVES CV OUTCOMES AND DECREASES RISK FOR NEW DIABETES IN HYPERTENSIVE PATIENTS WITH CAD 2004 ·Journal of Hypertension ·A. Benetos, Ann C. Hewkin, Stuart Kupfer, Carl J. Pepine	1
15	STROKE OUTCOME IN HYPERTENSIVE CAD PATIENTS TREATED WITH VERAPAMIL SR- (VE) AND ATENOLOL-(AT) BASED STRATEGIES 2004 ·Journal of Hypertension ·António Coca, A. Bénétos, Ann C. Hewkin, Annette Champion, Carl J. Pepine	2
16	Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study) 2002 ·The American Journal of Cardiology ·Thomas Meinertz, Gregory Y.H. Lip, Federico Lombardi, (unknown), (unknown), Anne Camez, Ann C. Hewkin, (unknown)	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact